SCHEMBL7515189

SCHEMBL7515189

Cc1ccc(N)c2c(=O)c(C(=O)O)c[nH]c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49
▸ CSNK2A1 P68400 5/20 0.47
▸ CSNK2A2 P19784 4/20 0.47
▸ CSNK2B P67870 4/20 0.47
▸ PIM3 Q86V86 1/20 0.44
▸ CLK4 Q9HAZ1 1/20 0.44
▸ KDM4E B2RXH2 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ HPGD P15428 2/20 0.43
▸ DNA2 P51530 1/20 0.39
▸ CASP6 P55212 1/20 0.39
▸ CTDSP1 Q9GZU7 1/20 0.39
▸ BRPF1 P55201 1/20 0.39
▸ TET2 Q6N021 1/20 0.37
▸ TET1 Q8NFU7 1/20 0.37
▸ NOTUM Q6P988 1/20 0.37
▸ POLB P06746 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ NR4A2 P43354 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3613665 0.79 BRPF1 (0.46) CYP1A2HSD17B10CSNK2A1CSNK2A2CSNK2B
SCHEMBL7512239 0.77 DNA2 (0.56) CYP1A2HSD17B10CSNK2A1CSNK2A2CSNK2B
SCHEMBL7559605 0.75 CSNK2A1 (0.43) CYP1A2HSD17B10CSNK2A1CSNK2A2CSNK2B
SCHEMBL1275907 0.73 ADRA2A (0.50) CYP1A2HSD17B10CSNK2A1CSNK2A2CSNK2B
SCHEMBL2977498 0.72 KDM4E (0.67) CYP1A2HSD17B10CSNK2A1CSNK2A2CSNK2B
Hydrochloric Acid SCHEMBL28606562 0.71 KDM4E (0.65) CYP1A2HSD17B10CSNK2A1CSNK2A2CSNK2B
SCHEMBL2309708 0.69 HSD17B10 (0.55) CYP1A2HSD17B10CSNK2A1CSNK2A2CSNK2B
SCHEMBL4339753 0.69 CSNK2A2 (0.63) CYP1A2HSD17B10CSNK2A1CSNK2A2CSNK2B
SCHEMBL12708943 0.69 CLEC4M (0.60) CYP1A2HSD17B10KDM4EALDH1A1HPGD
SCHEMBL10839866 0.68 KDM4E (0.65) CYP1A2HSD17B10CSNK2A1CSNK2A2CSNK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020193591-A1 Process for producing 5-amino-8-alkylquinolonecarboxylic acid derivative and intermediates in the production thereof DAIICHI PHARMACEUTICAL CO., LTD. 2002-12-19 — — US disclosed
EP-1167344-A1 PROCESS FOR PRODUCING 5-AMINO-8- ALKYLQUINOLO NECARBOXYLIC ACID DERIVATIVES AND INTERMEDIATES IN THE PRODUCTION THEREOF DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2002-01-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020193591-A1 Process for producing 5-amino-8-alkylquinolonecarboxylic acid derivative and intermediates in the production thereof SQOR, XDH, SPOUT1 CYP1A2 255/4885HSD17B10 1257/4885CSNK2A1 1882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback